B-CAP (Brentuximab Vedotin, Cyclophosphamide, Doxorubicin and predniso(lo)Ne) in older patients with advanced-stage hodgkin lymphoma: results of a phase II intergroup trial By the German Hodgkin study group (GHSG) and the Nordic Lymphoma group (NLG)
2019
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI